XBIO Xenetic Biosciences, Inc.

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics.

$2.52
As of 07/23/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  04/17/2014
Outstanding shares:  8,746,692
Average volume:  16,043,844
Market cap:   $16,268,847
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    984015206
ISIN:        
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -1.99
PB ratio:   2.01
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%